Trials / Terminated
TerminatedNCT03796871
Medical Device Based on Polarized Light for Cutaneous Lesions Visualization
Interest of a New Medical Device for the Visualization of Cutaneous Lesions Based on Polarized Light
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Skin cancers represent a real public health issue. The diagnosis of pre-cancerous lesions thus is a priority. The diagnosis gold standard is based on the combination of clinical and histopathological examinations. Nevertheless, the clinical examination is not sufficiently effective, meaning that a biopsy has to be done for each suspected lesion. In order to avoid unnecessary biopsy excisions, a new medical device (DERMAPOL) was designed to help dermatologists in diagnosing skin lesions. This medical device combined with its software is a strong and ergonomic spectro-polarimetric imager instrument. It can realize images of the superficial cutaneous tissues and subcutaneous tissues close to the surface by exploiting polarized light properties. This first clinical trial aims to demonstrate that this medical device is able to segment effectively healthy and tumor tissues and that it can correlate main semiological elements (identified thanks to the clinical and histopathological examinations) to the physico-optical characteristics obtained on the images of the medical device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Dermapol | Use of the experimental medical device before lesion excision : skin lesion lighting (4 wavelengths) for less than 1 minute and image recording |
Timeline
- Start date
- 2019-06-19
- Primary completion
- 2024-01-14
- Completion
- 2024-01-14
- First posted
- 2019-01-08
- Last updated
- 2025-08-03
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03796871. Inclusion in this directory is not an endorsement.